World

UAE-Bahrain Diplomatic Cooperation Working Group holds meeting

Sep 01, 2023

Abu Dhabi [UAE],September 1: Reflecting the deep-rooted historical and fraternal ties and strategic cooperation between the United Arab Emirates and the Kingdom of Bahrain, a Diplomatic Cooperation Working Group meeting took place today in Abu Dhabi between the Foreign Ministries of the two countries.
The meeting was convened following the outcomes of the 10th session of the UAE-Bahrain Joint Committee meeting held on 23rd October, 2022, in Manama.
The meeting was co-chaired by Khalifa Shaheen Al Marar, Minister of State, and Dr. Shaikh Abdulla bin Ahmed Al Khalifa, Under-Secretary for Political Affairs at the Ministry of Foreign Affairs of Bahrain.
Al Marar welcomed Dr. Al Khalifa and the Bahraini delegation and commended the close bilateral ties between the UAE and the Kingdom of Bahrain, which are based on deep relations between the two countries and the distinguished and solid historical ties between the leaderships of President His Highness Sheikh Mohamed bin Zayed Al Nahyan, and His Majesty King Hamad bin Isa Al Khalifa of Bahrain.
Al Marar emphasised the keenness of the two countries to further enhance relations and the importance of continued consultation within the framework of joint coordination for the benefit of both nations and peoples.
Source: Emirates News Agency

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025